(E)-4-(hex-1-en-1-yl)-1,2-dimethoxybenzene | 68719-75-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-4-(hex-1-en-1-yl)-1,2-dimethoxybenzene
• 英文别名: (E)-4-(hex-1-enyl)-1,2-dimethoxybenzene；4-[(E)-hex-1-enyl]-1,2-dimethoxybenzene
• CAS: 68719-75-5
• 化学式: C₁₄H₂₀O₂
• 分子量: 220.312
• InChiKey: ALOPSPTYVXRSCA-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,2-二甲基-2,6-二氢-吡喃并[3,2-c]喹啉-5-酮 、 (E)-4-(hex-1-en-1-yl)-1,2-dimethoxybenzene 以 neat (no solvent) 为溶剂， 反应 16.0h， 以7%的产率得到(1RS,2RS,2aRS,10aSR)-1-butyl,10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3H-cyclobuta[4,5]pyrano[3,2-c]quinolin-3-one
  参考文献：
  名称：

  Euodenine A: A Small-Molecule Agonist of Human TLR4

  摘要：

  A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.

  DOI：

  10.1021/jm401321v
• 作为产物：
  描述：

  正戊基溴化镁 在 silica gel 作用下， 以 1,4-二氧六环 、 乙醚 、 甲苯 为溶剂， 反应 16.0h， 生成 (E)-4-(hex-1-en-1-yl)-1,2-dimethoxybenzene
  参考文献：
  名称：

  Euodenine A: A Small-Molecule Agonist of Human TLR4

  摘要：

  A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.

  DOI：

  10.1021/jm401321v

文献信息

• A transition-metal-free Heck-type reaction between alkenes and alkyl iodides enabled by light in water
  作者：Wenbo Liu、Lu Li、Zhengwang Chen、Chao-Jun Li

  DOI：10.1039/c5ob00515a

  日期：——

  A transition-metal-free coupling protocol between various alkenes and non-activated alkyl iodides has been developed by using photoenergy in water for the first time. Under UV irradiation and basic aqueous conditions, various alkenes efficiently couple with a wide range of non-activated alkyl iodides. A tentative mechanism, which involves an atom transfer radical addition process, for the coupling

  首次通过在水中使用光能，开发了各种烯烃与未活化烷基碘之间的无过渡金属偶联方案。在紫外线辐射和碱性水溶液条件下，各种烯烃与各种未活化的烷基碘有效地偶联。提出了一种涉及原子转移自由基加成过程的偶合机理。
• Olefination of activated halides and mesylates using arsonium ylides
  作者：André Seyer、Lilian Alcaraz、C. Mioskowski

  DOI：10.1016/s0040-4039(97)10152-6

  日期：1997.11

  Alkyltriphenylarsonium ylides react with activated primary halides and mesylates to afford olefins in good yields and with high E-selectivity. (C) 1997 Elsevier Science Ltd.
• Pharmacology on rat ileum of certain 2-substituted 3-(dimethylamino)-5,6-dimethoxyindenes related to 5,6-(methylendioxy)indene calcium antagonist
  作者：Donald T. Witiak、Sunil V. Kakodkar、George E. Brunst、John R. Baldwin、Ralf G. Rahwan

  DOI：10.1021/jm00210a028

  日期：1978.12

  Whereas the 2-propyl- and 2-butyl-5,6-(methylenedioxy)indene calcium antagonists reversed the spasmogenic action of several agonists including PGF2alpha and acetylcholine at 5 X 10(-5) to 10(-4) M on the rat ileum, the corresponding 5,6-dimethoxy analogues exhibited spasmogenic activity at higher concentration (10(-4)-10(-3) M) and exhibited neither spasmogenic nor spasmolytic activity at lower (10(-6)-10(-5) M) concentration. The results are compared to the methyl and 2-ethyl analogues. At 10(-4) M only the butyl analogue was capable of moderate antagonism of acetylcholine and at 10(-3) M all four analogues were capable of moderately antagonizing the actions of acetylcholine.
• Euodenine A: A Small-Molecule Agonist of Human TLR4
  作者：Juliette E. Neve、Hasanthi P. Wijesekera、Sandra Duffy、Ian D. Jenkins、Justin A. Ripper、Simon J. Teague、Marc Campitelli、Agatha Garavelas、George Nikolakopoulos、Phuc V. Le、Priscila de A. Leone、Ngoc B. Pham、Philip Shelton、Neil Fraser、Anthony R. Carroll、Vicky M. Avery、Christopher McCrae、Nicola Williams、Ronald J. Quinn

  DOI：10.1021/jm401321v

  日期：2014.2.27

  A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.